Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 5;10(8):e6009.
doi: 10.1002/ccr3.6009. eCollection 2022 Aug.

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia

Affiliations
Case Reports

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia

Farinoosh Dadrass et al. Clin Case Rep. .

Abstract

Acute myeloid leukemia (AML) arises from clonal expansion of malignant hematopoietic precursor cells in the bone marrow. In rare instances, AML can recur with prominent extramedullary manifestations (i.e., leukemia cutis or myeloid sarcoma), either simultaneously or preceding marrow involvement, or as a sole site of primary disease relapse.

Keywords: AML; MLL gene; MLL rearrangement; acute myeloid leukemia; leukemia; leukemia cutis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Initial diagnosis of AML and relapse following remission of AML. (A) BMB at the time of diagnosis reveals hypercellular marrow for age with markedly decreased trilineage hematopoiesis (4× magnification). (B) On higher power, the leukemic blast cells show prominent nucleoli and scant cytoplasm (40× magnification). (C) Dermatological physical exam was remarkable for a 2 cm × 1.5 cm thin pink purple plaque on her right lower back. (D) Histopathologic sections show an unremarkable epidermis with an underlying atypical infiltrate of immature hematopoietic blasts extensively involving the dermis and underlying subcutaneous adipose tissue (4× magnification). (E) On higher power, the immature blasts show enlarged nuclei with prominent nucleoli and amphophilic cytoplasm (40× magnification). (F) CD117 immunohistochemical stain shows that the majority of neoplastic cells are positive for CD117 (40× magnification). (G) Recent bone marrow biopsy shows trilineage hematopoiesis with no morphological evidence of involvement by leukemic blast cells. (4× magnification)

References

    1. Estey EH. Acute myeloid leukemia: 2021 update on risk‐stratification and management. Am J Hematol. 2020;95(11):1368‐1398. doi:10.1002/ajh.25975 - DOI - PubMed
    1. Kantarjian H, Kadia T, DiNardo C, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41. doi:10.1038/s41408-021-00425-3 - DOI - PMC - PubMed
    1. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107(9):3481‐3485. doi:10.1182/blood-2005-09-3724 - DOI - PMC - PubMed
    1. Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J (2013). 2020;103(3):38‐40. - PubMed
    1. Pollyea DA, Pratz K, Letai A, et al. Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: long term follow‐up from a phase 1b study. Am J Hematol. 2020;96:208‐217. doi:10.1002/ajh.26039 - DOI - PubMed

Publication types

LinkOut - more resources